Project Grant 2049600
Award Date
7/15/21
Completion Date
6/30/22
Dollars Obligated
$256K
Federal Agency
National Science Foundation
Federal Grant Program
47.084
Assistance Type
Project Grant
Place of Performance
San Francisco, CA 94107, USA
Similar Awards
This Small Business Innovation Research (SBIR) Phase II Cooperative Agreement award from the National Science Foundation (CFDA 47.084 - NSF Technology, Innovation, and Partnerships) provides $999,545 to Senoguard Inc. to complete engineering and validation activities for a novel minimally invasive cryoablation probe and external controller system. The goal is to develop an adjunctive therapy that can be performed by breast cancer surgeons immediately following a lumpectomy to reduce or eliminate...
The National Science Foundation awarded a $255,731 Small Business Innovation Research Phase I Project Grant to Senoguard Inc. under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084). The grant funds the development and preclinical testing of a novel cryoablation probe system for post-lumpectomy margin ablation cancer treatment. Specifically, the company will design and optimize the probe for optimal contact and thermal transfer with tumor cells in fixed in vitro testing. The...
The National Science Foundation (NSF) awarded a $275,000 Small Business Innovation Research (SBIR) Phase I project grant to Agil Therapeutics Inc. under the NSF Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084). This two-year project aims to develop a novel cryoablation system for minimally invasive treatment of type 2 diabetes. The system is designed to deliver a highly controlled and targeted cryogenic agent to the duodenum, with the goal of remodeling the duodenal tissue to...
This $300,000 Project Grant awarded by the National Science Foundation (NSF) under the Integrative Activities (CFDA 47.083) program supports the development of an innovative, intelligent surgical probe for prostate cancer treatment. The project aims to create an edge artificial intelligence (AI) system-on-chip for bioimpedance analysis that can accurately distinguish cancerous from healthy tissue during prostate removal surgery. The novel technology being developed includes an adaptive filter to...
Altyx Surgical, Inc. received a $256,000 Project Grant award from the National Science Foundation Division of Industrial Innovation under the Engineering federal grant program (CFDA 47.041) to develop a mesh-free, sling-free, minimally invasive treatment for stress urinary incontinence in women. The award, issued on August 1, 2021, supports the company's STTR Phase I research through January 31, 2022 to advance its development of an innovative surgical solution for this condition. The National...
The National Science Foundation awarded $256,000 to Optave Diagnostics LLC through the Technology, Innovation, and Partnerships program (CFDA 47.084) to develop a prototype endoscopic probe for molecular imaging and diagnosis of cancerous prostate pathologies. The 12-month project grant will support the creation of a medical device using photoacoustic imaging and acoustic lens technology to aid in the detection and diagnosis of prostate cancer. The proposed endoscopic probe offers an alternative...
This Project Grant award from the National Cancer Institute (NCI), under the Federal Assistance Listings program CFDA 93.395 Cancer Treatment Research, provides $406,500.00 to support the development of a novel, low-cost, single-use trans-nasal cryotherapy device for esophageal cancer treatment in low-resource settings. The project aims to design and validate a functional prototype of this first-of-its-kind device, which would enable unsedated cryoablation procedures to be administered through...
This $275,000 Small Business Technology Transfer (STTR) Phase I grant from the National Science Foundation (CFDA 47.084 - NSF Technology, Innovation, and Partnerships program) was awarded to Oncoblaze LLC to develop a novel device for targeted delivery of chemotherapy agents to tissue surrounding surgically removed tumors. The project aims to address the issue of tumor recurrence after cancer surgery, which affects 30-40% of patients for certain cancers. The device uses an infrared laser to heat...
The National Science Foundation awarded a $256,000 Small Business Innovation Research Phase I Project Grant to Current Surgical Inc. from May 15, 2021 to November 30, 2021 under the Engineering program (CFDA 47.041). The grant funds the development of a smart needle for precise tumor ablation. The NSF Engineering program supports innovation, creativity, and excellence in engineering research and education to improve quality of life and economic strength. This award advances those goals by...
Acatechol, Inc. was awarded a $274,982 National Science Foundation (NSF) Small Business Innovation Research (SBIR) Phase I grant to develop an innovative anti-infective coating for Foley catheters. The project aims to create a hybrid coating that combines biofilm-repellent and antimicrobial properties to provide prolonged resistance against pathogen colonization and catheter-associated urinary tract infections (CAUTIs). This work is being conducted under the NSF Technology, Innovation, and...